Stocktoria

BioCardia, Inc. BCDA

Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 1996-11-13 · LEI

BioCardia, Inc. statistics & valuation

Market cap$17.9M
P / B20.0×
Return on capital-843.8%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
2018201920202021202220222023202320242025
Operating margin (%)
-2256.30% -2001.80% -10709.70% -1244.30% -880.30% -2441.10% -13794.80% 2018201920202021202220222023202320242025
Return on equity (%)
-368.90% -620.60% -78.20% -121.70% -243.40% -949.30% -919.30% 2018201920202021202220222023202320242025
Shares outstanding
4.8M 6.8M 16.3M 16.9M 16.9M 20.1M 20.2M 1.6M 4.6M 10.8M 2018201920202021202220222023202320242025
Net debt ($)
2018201920202021202220222023202320242025
Share buybacks ($)
2018201920202021202220222023202320242025
Return on assets (%)
-218.00% -191.60% -64.10% -80.30% -121.60% -387.40% -213.40% -241.10% 2018201920202021202220222023202320242025
Free cash flow margin (%)
-1781.60% -1350.80% -8544.10% -1032.70% -786.30% -2093.50% -13606.90% 2018201920202021202220222023202320242025
Debt / equity (×)
2018201920202021202220222023202320242025
EPS ($)
2018201920202021202220222023202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2023FY2022FY2022FY2021FY2020FY2019FY2018
Operating margin—-13794.8%-2441.1%—-880.3%—-1244.3%-10709.7%-2001.8%-2256.3%
Net margin—-13700.0%-2425.8%—-880.7%—-1243.6%-10347.6%-2071.7%-2237.9%
FCF margin—-13606.9%-2093.5%—-786.3%—-1032.7%-8544.1%-1350.8%-1781.6%
Return on assets-241.1%-213.4%-387.4%—-121.6%—-80.3%-64.1%-191.6%-218.0%
Return on equity-919.3%-949.3%721.8%—-243.4%—-121.7%-78.2%-620.6%-368.9%
Current ratio1.121.130.401.322.192.723.635.331.592.44

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.